NCI and industry: Moving innovations from the lab to patients
Interviewee/Contributor
Michael Salgaller and Michele Newton
Organisation
US National Cancer Institute
Drug discovery
Will gene editing unmask synthetic lethal targets?
Interviewee/Contributor
Ceri Wiggins and Jon Moore
Organisation
Horizon Discovery Group Plc
The need for innovation in neuroscience
Interviewee/Contributor
Jean-Claude Muller
Organisation
MedNous
Meeting Report: Funding rises for early assets
Interviewee/Contributor
Søren Møller
Organisation
Novo Seeds
The productivity of oncology development continues
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Exscientia raises $26 million, partners with Roche
Interviewee/Contributor
Andrew Hopkins
Organisation
Exscientia Ltd
IMI: Building a science infrastructure for Europe
Interviewee/Contributor
Pierre Meulien
Organisation
Innovative Medicines Initiative
A strategy for using AI in pharma R&D
Interviewee/Contributor
Ed Corbett
Organisation
Novasecta Ltd
Light on the horizon for Swedish biopharma
Interviewee/Contributor
Søren Tulstrup
Organisation
Hansa Medical AB
Galecto raises €79 million in Series C round
Interviewee/Contributor
Karen Wagner
Organisation
Ysios Capital